Navigation Links
HIV did not arise from polio vaccine

Researchers in four countries have unanimously opined that the deadly Human Immune Deficiency Virus (HIV) Epidemic did not arise from an oral polio vaccine used in Africa in the 1950s and say rumours suggesting the contrary have no scientific evidence to back them up.

The studies, from researchers in the US, UK, France and Germany, should help free the polio vaccine manufactured by the Wistar Institute in Philadelphia, Pennsylvania, from lingering questions over its proposed role in creating the HIV scourge.

The research into the origin of HIV started when rumours started flying thick and fast that HIV originated from the Wistar vaccine used in a 1950s anti-polio campaign in Africa. These vaccines were allegedly cultured in chimpanzee kidney cells. These chimp cells, some say, may have been contaminated with the virus that became HIV-1, the strain responsible for most of the world's HIV infections. The Wistar Institute has always denied that any chimp cells were used in manufacturing its OPV.

But the fact that mainstream researchers believe HIV arose from the related Simian Immunodeficiency virus (SIV) in chimps has bolstered the idea that HIV was mistakenly unleashed through polio vaccination. The theory was first made famous in a 1992 Rolling Stone article, and the idea gained more steam with the 1999 publication of journalist Edward Hooper's book "The River."

But in new findings published in the journals Nature and Science, four research teams demonstrate that the Wistar vaccine did not contain chimp cells and that the virus that would become HIV likely jumped from chimps to humans just once--and not through a massive, simultaneous transfer, as it would if vaccination were to blame.

Though these findings are not sufficient to convince all skeptics, atleast a vast majority of the scientific community now feel convinced that the oral polio vaccine was not the villain that unleashed HIV on the human race.
'"/>




Page: 1

Related medicine news :

1. Malignant virus in polio vaccine combined to Cancer
2. 1.8 mn Delhi Children to Receive Anti-polio Drops
3. New polio cases detected in Bihar
4. Madhya Pradesh battles polio with yet another drive
5. Delhi children to receive anti-polio drops Sunday
6. New hope for cancer victims – will vaccine cure the deadly bug
7. New vaccine helps allergy and asthma patients
8. Man against HIV – new vaccine ready for human trials
9. New vaccine helps allergy and asthma patients
10. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
11. Double impact vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/26/2017)... ... July 26, 2017 , ... An inventor from Salisbury, N.C., ... haven’t yet seen an effective and dignified way to keep leeches in place during ... CUP." , This invention provides an effective way to keep a leech in place ...
(Date:7/26/2017)... ... July 26, 2017 , ... A major challenge many labs ... freeze drying samples and a lengthy freeze dry cycle are a few common challenges ... drying techniques, as well as new accessories and advancements in laboratory freeze dryers that ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... the cloud ; today announced the availability of its latest data protection solution ... use control console for Data Discovery, Classification, Encryption and Digital Rights Management; GTB ...
(Date:7/26/2017)... , ... July 26, 2017 , ... ... or “Isodiol”) a global cannabis innovator, specializing in the development of pharmaceutical and ... from April 1, 2017 to June 30, 2017. Iso International LLC recorded unaudited ...
(Date:7/25/2017)... St. Louis, MO (PRWEB) , ... July 25, 2017 , ... ... (HDIS) in St. Louis, Missouri. The company has achieved record-breaking sales for ... multiple departments over the next 12 months. , The upcoming year offers excitement and ...
Breaking Medicine News(10 mins):
(Date:7/27/2017)... EXTON, Pa., July 27, 2017  West Pharmaceutical Services, ... financial results for the second-quarter 2017 and updated financial ... Second-Quarter 2017 Highlights Reported ... 2.5% over the prior-year quarter. Net sales at constant ... 2017 reported-diluted EPS was $0.51, compared to $0.60 in ...
(Date:7/26/2017)... NEW YORK , July 26, 2017 ... Annual Prix Galien USA Award ... honors, the Prix Galien Award recognizes outstanding biomedical and technology ... To qualify, each candidate must be ... the last five years and demonstrate tremendous potential to impact ...
(Date:7/24/2017)... 24, 2017  Diplomat Pharmacy, Inc. (NYSE: ... second quarter 2017 operating results on Monday, August 7, ... follow at 5:00 p.m. ET. ... a live broadcast of the conference call by dialing ... code 51641230 approximately 15 minutes prior to the call. ...
Breaking Medicine Technology: